176 related articles for article (PubMed ID: 37210452)
1. Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Endo Y; Yang J; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5406-5415. PubMed ID: 37210452
[TBL] [Abstract][Full Text] [Related]
2. The Application of Artificial Intelligence to Investigate Long-Term Outcomes and Assess Optimal Margin Width in Hepatectomy for Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Endo Y; Lima HA; Butey SP; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Kim A; Ejaz A; Beane J; Cloyd J; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4292-4301. PubMed ID: 36952150
[TBL] [Abstract][Full Text] [Related]
3. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
[TBL] [Abstract][Full Text] [Related]
4. Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.
Fu J; Zheng L; Tang S; Lin K; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Wang K; Li H; Zeng Y
BMC Cancer; 2024 Mar; 24(1):358. PubMed ID: 38509498
[TBL] [Abstract][Full Text] [Related]
5. Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
Alaimo L; Moazzam Z; Brown ZJ; Endo Y; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1340-1349. PubMed ID: 36029379
[TBL] [Abstract][Full Text] [Related]
6. Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma.
Jolissaint JS; Wang T; Soares KC; Chou JF; Gönen M; Pak LM; Boerner T; Do RKG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR; Chakraborty J
HPB (Oxford); 2022 Aug; 24(8):1341-1350. PubMed ID: 35283010
[TBL] [Abstract][Full Text] [Related]
7. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
[TBL] [Abstract][Full Text] [Related]
8. Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.
Bo Z; Chen B; Yang Y; Yao F; Mao Y; Yao J; Yang J; He Q; Zhao Z; Shi X; Chen J; Yu Z; Yang Y; Wang Y; Chen G
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2501-2513. PubMed ID: 36922449
[TBL] [Abstract][Full Text] [Related]
9. Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
Xie H; Hong T; Liu W; Jia X; Wang L; Zhang H; Xu C; Zhang X; Li WL; Wang Q; Yin C; Lv X
BMC Gastroenterol; 2024 Apr; 24(1):137. PubMed ID: 38641789
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1392-1403. PubMed ID: 36383331
[TBL] [Abstract][Full Text] [Related]
12. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
[TBL] [Abstract][Full Text] [Related]
13. Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma.
Kawashima J; Sahara K; Shen F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Cauchy F; Koerkamp BG; Matsuyama R; Endo I; Pawlik TM
J Gastrointest Surg; 2024 Jan; 28(1):18-25. PubMed ID: 38353070
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
15. Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma.
Endo Y; Sasaki K; Moazzam Z; Lima HA; Alaimo L; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2023-2032. PubMed ID: 36396868
[TBL] [Abstract][Full Text] [Related]
16. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
Moazzam Z; Alaimo L; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Cloyd J; Ejaz A; Pawlik TM
J Am Coll Surg; 2023 Apr; 236(4):804-813. PubMed ID: 36728327
[TBL] [Abstract][Full Text] [Related]
17. Predicting overall and recurrence-free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi-institutional analysis.
Shaikh CF; Alaimo L; Moazzam Z; Endo Y; Lima HA; Dawood Z; Munir MM; Pawlik TM
J Surg Oncol; 2023 Jan; 127(1):73-80. PubMed ID: 36106350
[TBL] [Abstract][Full Text] [Related]
18. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
19. A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm.
Sahara K; Tsilimigras DI; Mehta R; Bagante F; Guglielmi A; Aldrighetti L; Alexandrescu S; Marques HP; Shen F; Koerkamp BG; Endo I; Pawlik TM
J Surg Oncol; 2019 Aug; 120(2):223-230. PubMed ID: 31004365
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
